{"transactions":[{"id":961748,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":71075,"kind":"person","name":"Payne Joseph E","position":1,"cik":"0001727315","reported_name":"Payne Joseph E","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-12-19T17:21:26.000Z","date":"2025-12-17","kind":"grant","planned":false,"acquired":true,"shares":175000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents options to purchase shares of common stock granted pursuant to the Company's Amended and Restated 2019 Omnibus Equity Incentive Plan, as amended."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying this option vest 25% on December 17, 2026, the first anniversary of the date of grant, and the remainder vest in equal increments on each successive one-month anniversary thereafter for the next thirty-six months."}],"balance_after":175000,"derivative":{"exercise_price":6.52,"expiration_date":"2035-12-17","underlying":"Common Stock","underlying_shares":175000},"source":{"system":"sec-edgar","filing":"0001193805-25-001765","document":"e665059_4-payne.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1727315/000119380525001765/e665059_4-payne.xml","form_type":"4"}},{"id":1326126,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":71075,"kind":"person","name":"Payne Joseph E","position":1,"cik":"0001727315","reported_name":"Payne Joseph E","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-12-18T16:06:59.000Z","date":"2024-12-16","kind":"grant","planned":false,"acquired":true,"shares":196000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents options to purchase shares of common stock granted pursuant to the Company's Amended and Restated 2019 Omnibus Equity Incentive Plan, as amended."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying this option vest 25% on December 16, 2025, the first anniversary of the date of grant, and the remainder vest in equal increments on each successive one-month anniversary thereafter for the next thirty-six months."}],"balance_after":196000,"derivative":{"exercise_price":16.24,"expiration_date":"2034-12-16","underlying":"Common Stock","underlying_shares":196000},"source":{"system":"sec-edgar","filing":"0001193805-24-001492","document":"e664085_4-payne.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1727315/000119380524001492/e664085_4-payne.xml","form_type":"4"}},{"id":1704132,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":71075,"kind":"person","name":"Payne Joseph E","position":1,"cik":"0001727315","reported_name":"Payne Joseph E","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-12-19T20:00:19.000Z","date":"2023-12-15","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents options to purchase shares of common stock granted pursuant to the Company's Amended and Restated 2019 Omnibus Equity Incentive Plan, as amended."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying this option vest 25% on December 15, 2024, the first anniversary of the date of grant, and the remainder vest in equal increments on each successive one-month anniversary thereafter for the next thirty-six months."}],"balance_after":200000,"derivative":{"exercise_price":28.88,"expiration_date":"2033-12-15","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001193805-23-001626","document":"e619133_4-payne.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1727315/000119380523001626/e619133_4-payne.xml","form_type":"4"}},{"id":2087415,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":71075,"kind":"person","name":"Payne Joseph E","position":1,"cik":"0001727315","reported_name":"Payne Joseph E","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-12-13T16:07:38.000Z","date":"2022-12-09","kind":"grant","acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents options to purchase shares of common stock approved by the Board of Directors on December 9, 2022 pursuant to the Company's Amended and Restated 2019 Omnibus Equity Incentive Plan, as amended."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying this option vest 25% on December 9, 2023, the first anniversary of the date this award was approved by the Board of Directors, and the remainder vest in equal increments on each successive one-month anniversary thereafter for the next thirty-six months."}],"balance_after":250000,"derivative":{"exercise_price":16.92,"expiration_date":"2032-12-09","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001193805-22-001715","document":"e618108_4-payne.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1727315/000119380522001715/e618108_4-payne.xml","form_type":"4"}},{"id":2103124,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":71075,"kind":"person","name":"Payne Joseph E","position":1,"cik":"0001727315","reported_name":"Payne Joseph E","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-11-28T16:07:25.000Z","date":"2022-11-23","kind":"purchase","acquired":true,"shares":5000,"price":16.51,"value":82550.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the purchase price paid by the Reporting Person for the shares of common stock, $0.001 par value per share, of the Registrant, in an open market transaction."}],"balance_after":1480097,"source":{"system":"sec-edgar","filing":"0001193805-22-001614","document":"e618061_4-payne.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1727315/000119380522001614/e618061_4-payne.xml","form_type":"4"}},{"id":2222692,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":71075,"kind":"person","name":"Payne Joseph E","position":1,"cik":"0001727315","reported_name":"Payne Joseph E","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-06-23T16:16:39.000Z","date":"2022-06-21","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents options to purchase shares of common stock conditionally approved by the Board of Directors on December 10, 2021, subject to approval of an amendment to the Company's Amended and Restated 2019 Omnibus Equity Incentive Plan by the Company's stockholders, which approval was obtained at the Company's 2022 Annual Meeting of Stockholders held on June 21, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying this option vest 25% on December 10, 2022, the first anniversary of the date this award was conditionally approved by the Board of Directors, and the remainder vest in equal increments on each successive one-month anniversary thereafter for the next thirty-six months."}],"balance_after":150000,"derivative":{"exercise_price":34.57,"expiration_date":"2031-12-10","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001193805-22-001001","document":"e621772_4-payne.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1727315/000119380522001001/e621772_4-payne.xml","form_type":"4"}},{"id":2235292,"issuer":{"id":8336,"kind":"organization","name":"GRI Bio, Inc."},"owners":[{"id":71075,"kind":"person","name":"Payne Joseph E","position":1,"cik":"0001727315","reported_name":"Payne Joseph E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-10T13:32:00.000Z","date":"2022-06-09","kind":"grant","acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests in four equal quarterly installments such that the stock option is fully vested on the first anniversary of the date of grant."}],"balance_after":7500,"derivative":{"exercise_price":0.51,"expiration_date":"2032-06-09","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001824293-22-000055","document":"wf-form4_165488230708266.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1727315/000182429322000055/wf-form4_165488230708266.xml","form_type":"4"}},{"id":2692554,"issuer":{"id":8336,"kind":"organization","name":"GRI Bio, Inc."},"owners":[{"id":71075,"kind":"person","name":"Payne Joseph E","position":1,"cik":"0001727315","reported_name":"Payne Joseph E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-27T20:37:49.000Z","date":"2021-05-26","kind":"purchase","acquired":true,"shares":6800,"price":4.5,"value":30600.0,"ownership":{"direct":true},"balance_after":17500,"source":{"system":"sec-edgar","filing":"0001104659-21-073495","document":"tm2117820-1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1727315/000110465921073495/tm2117820-1_4.xml","form_type":"4"}},{"id":2692553,"issuer":{"id":8336,"kind":"organization","name":"GRI Bio, Inc."},"owners":[{"id":71075,"kind":"person","name":"Payne Joseph E","position":1,"cik":"0001727315","reported_name":"Payne Joseph E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-27T20:37:49.000Z","date":"2021-05-25","kind":"purchase","acquired":true,"shares":10700,"price":3.85,"value":41195.0,"ownership":{"direct":true},"balance_after":10700,"source":{"system":"sec-edgar","filing":"0001104659-21-073495","document":"tm2117820-1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1727315/000110465921073495/tm2117820-1_4.xml","form_type":"4"}},{"id":2707100,"issuer":{"id":8336,"kind":"organization","name":"GRI Bio, Inc."},"owners":[{"id":71075,"kind":"person","name":"Payne Joseph E","position":1,"cik":"0001727315","reported_name":"Payne Joseph E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-05-18T16:09:13.000Z","date":"2021-05-14","kind":"grant","acquired":true,"shares":14286,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests as to 50% of the underlying shares of common stock on June 30, 2021, then in two equal installments on September 30, 2021 and December 31, 2021, such that the stock option fully vests on December 31, 2021."}],"balance_after":14286,"derivative":{"exercise_price":3.66,"expiration_date":"2031-05-14","underlying":"Common Stock","underlying_shares":14286},"source":{"system":"sec-edgar","filing":"0001104659-21-068839","document":"tm2116776-7_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1727315/000110465921068839/tm2116776-7_4.xml","form_type":"4"}},{"id":2707099,"issuer":{"id":8336,"kind":"organization","name":"GRI Bio, Inc."},"owners":[{"id":71075,"kind":"person","name":"Payne Joseph E","position":1,"cik":"0001727315","reported_name":"Payne Joseph E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-05-18T16:09:13.000Z","date":"2021-05-14","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests in 24 equal monthly installments such that the stock option is fully vested on the second annual anniversary of the date of grant."}],"balance_after":15000,"derivative":{"exercise_price":3.66,"expiration_date":"2031-05-14","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001104659-21-068839","document":"tm2116776-7_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1727315/000110465921068839/tm2116776-7_4.xml","form_type":"4"}},{"id":2934088,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":71075,"kind":"person","name":"Payne Joseph E","position":1,"cik":"0001727315","reported_name":"Payne Joseph E","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2020-12-22T19:40:19.000Z","date":"2020-12-18","kind":"grant","acquired":true,"shares":175000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares underlying the option vest on the one year anniversary of the date of grant, with the remainder vesting in 36 successive equal monthly increments thereafter."}],"balance_after":175000,"derivative":{"exercise_price":99.29,"expiration_date":"2030-12-18","underlying":"Common Stock","underlying_shares":175000},"source":{"system":"sec-edgar","filing":"0001193805-20-001609","document":"e620163_4-payne.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1727315/000119380520001609/e620163_4-payne.xml","form_type":"4"}},{"id":3114234,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":71075,"kind":"person","name":"Payne Joseph E","position":1,"cik":"0001727315","reported_name":"Payne Joseph E","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-06-10T21:59:45.000Z","date":"2020-06-10","kind":"purchase","acquired":true,"shares":1000,"price":31.69,"value":31690.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"183,137 shares are subject to repurchase by the Company."}],"balance_after":1475097,"source":{"system":"sec-edgar","filing":"0000899243-20-016050","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1727315/000089924320016050/doc4.xml","form_type":"4"}},{"id":3258691,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":71075,"kind":"person","name":"Payne Joseph E","position":1,"cik":"0001727315","reported_name":"Payne Joseph E","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2020-02-20T20:00:58.000Z","date":"2020-02-18","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares underlying the option vest on the one year anniversary of the date of grant, with the remainder vesting in 36 successive equal monthly increments thereafter."}],"balance_after":100000,"derivative":{"exercise_price":14.12,"expiration_date":"2030-02-18","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0000899243-20-005379","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1727315/000089924320005379/doc4.xml","form_type":"4"}},{"id":3425694,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":71075,"kind":"person","name":"Payne Joseph E","position":1,"cik":"0001727315","reported_name":"Payne Joseph E","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-08-30T17:00:34.000Z","date":"2019-08-29","kind":"purchase","acquired":true,"shares":5000,"price":11.22,"value":56100.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 366,274 ordinary shares subject to repurchase pursuant to a Common Stock Purchase Agreement, dated March 4, 2013, as amended on September 27, 2017, by and between the Reporting Person and the Issuer."}],"balance_after":1474097,"source":{"system":"sec-edgar","filing":"0000899243-19-022619","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1727315/000089924319022619/doc4.xml","form_type":"4"}},{"id":3665358,"issuer":{"id":160417,"kind":"organization","name":"Arcturus Therapeutics Ltd.","symbol":"ARCT"},"owners":[{"id":71075,"kind":"person","name":"Payne Joseph E","position":1,"cik":"0001727315","reported_name":"Payne Joseph E","relationship":{"director":false,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2019-02-11T16:21:32.000Z","date":"2019-02-07","kind":"grant","acquired":true,"shares":60000,"price":4.99,"value":299400.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The grant of options to the Reporting Person is subject to shareholder approval under the Companies Law 5759-1999 of the State of Israel; options vest over a period of four years from Vest Base Date, with 25% of the options vesting on the first anniversary thereof and the remainder vesting in equal monthly installments thereafter."}],"balance_after":60000,"derivative":{"exercise_price":4.99,"expiration_date":"2029-02-06","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001566049-19-000006","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1566049/000156604919000006/edgardoc.xml","form_type":"4"}}]}